International Pharmaceutical Business Expo – iPharma Expo 2021

International Pharmaceutical Business Expo - iPharma Expo 2021
International Pharmaceutical Business Expo - iPharma Expo 2021

International Pharmaceutical Business Expo- iPharma Expo 2021 scheduled during May 14-15, 2021 at Mumbai, IndiaiPharma Expo 2021 is expected to witness approx. 150 exhibitor’s and 1500- 2000 visitors footfall from pharma industry.

This expo will showcase the latest trends and technologies in pharmaceuticals, drugs and formulations and will bring together eminent personalities from various sectors of pharma, non-pharma and healthcare industries.

Register  for free at https://www.ipharmaexpo.com/visitor-registration/

iPharma Expo 2021 is expected to witness approx. 150 exhibitor’s and 1500- 2000 visitors footfall from pharma industry & management etc.  Brings unique platform for the participating companies to display their products & services to the gamut of visitors, globally from pharma and healthcare industries.

Know more- https://www.ipharmaexpo.com/

iPharma Expo, India provides direct access to highly targeted senior pharma executives, buyers, procurement managers, contract manufacturers, hospital administration and many more Meet the business development managers who are looking for new supplies, building strategic partnerships or entering into new ventures.

Whether you are looking for sourcing new business or getting the latest market insight, as well as the wholesalers and hospital purchase personnel’s who seek to buy bulk products on concessional rates this is your one-stop shop global pharma platform. Join us to expand your business presence in the leading pharmaceutical market India.

iPharma Expo - Rectangle Logo.png

Disclaimer: The views of authors published on South Africa Today are their own and do not necessarily represent the views of South Africa Today. By viewing, visiting, using, or interacting with SouthAfricaToday.net, you are agreeing to all the provisions of the Terms of Use Policy and the Privacy Policy.